Simplex Trading
AXSM icon

Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History

Simplex Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.07M Sell
11,200
-1,100
-9% -$239K ﹤0.01% 1952
2026
Q2 		$3.01M Sell
12,300
-5,600
-31% -$1.21M ﹤0.01% 1622
2026
Q1 		$3.03M Buy
17,900
+2,500
+16% +$432K ﹤0.01% 1494
2025
Q4 		$2.81M Sell
15,400
-39,900
-72% -$5.57M ﹤0.01% 1708
2025
Q3 		$6.72M Buy
55,300
+6,000
+12% +$676K ﹤0.01% 1224
2025
Q2 		$5.15M Sell
49,300
-11,900
-19% -$1.26M ﹤0.01% 1322
2025
Q1 		$7.14M Sell
61,200
-104,400
-63% -$11.9M ﹤0.01% 1085
2024
Q4 		$14M Buy
165,600
+115,300
+229% +$10.6M 0.01% 829
2024
Q3 		$4.52M Buy
50,300
+4,000
+9% +$349K ﹤0.01% 1566
2024
Q2 		$3.73M Sell
46,300
-16,100
-26% -$1.19M ﹤0.01% 1643
2024
Q1 		$4.98M Buy
62,400
+25,200
+68% +$2.12M ﹤0.01% 1608
2023
Q4 		$2.96M Buy
37,200
+4,400
+13% +$294K ﹤0.01% 2020
2023
Q3 		$2.29M Sell
32,800
-36,200
-52% -$2.71M ﹤0.01% 1958
2023
Q2 		$4.96M Sell
69,000
-27,400
-28% -$2.02M ﹤0.01% 1325
2023
Q1 		$5.94M Sell
96,400
-88,700
-48% -$5.83M 0.01% 1188
2022
Q4 		$14.3M Buy
185,100
+86,900
+88% +$5.19M 0.02% 699
2022
Q3 		$4.38M Sell
98,200
-21,900
-18% -$1.09M 0.01% 1290
2022
Q2 		$4.6M Buy
120,100
+60,700
+102% +$1.92M ﹤0.01% 1200
2022
Q1 		$2.46M Sell
59,400
-7,800
-12% -$242K ﹤0.01% 1893
2021
Q4 		$2.54M Buy
67,200
+61,800
+1,144% +$2.27M ﹤0.01% 1787
2021
Q3 		$368K Hold
5,400
– – ﹤0.01% 4566
2021
Q2 		$364K Buy
5,400
+5,313
+6,107% +$319K ﹤0.01% 4649
2021
Q1 		$492K Buy
+87
New +$6.12K ﹤0.01% 3401
2020
Q2 		– Sell
-701
Closed -$4.12M – 7583
2020
Q1 		$4.12M Sell
701
-351
-33% -$28.6K 0.01% 802
2019
Q4 		$10.9M Buy
1,052
+885
+530% +$35.7K 0.02% 436
2019
Q3 		$338K Sell
167
-205
-55% -$5.27K ﹤0.01% 3049
2019
Q2 		$957K Sell
372
-508
-58% -$10.2K ﹤0.01% 1943
2019
Q1 		$1.25M Buy
+880
New +$8.17K ﹤0.01% 1799

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Simplex Trading's AXSM Position: Q3 2026 in Review

Simplex Trading reduced its Axsome Therapeutics (AXSM) stake by 15% in Q3 2026, selling an estimated $628K and leaving 16,755 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Simplex Trading first reported a position in AXSM in Q3 2018 and has held it in 30 quarters since. The position peaked at $4.81M in Q2 2026. 235 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Simplex Trading held 16,755 shares of Axsome Therapeutics worth $3.09M as of Q3 2026.
  • Simplex Trading sold 2,888 Axsome Therapeutics shares in Q3 2026, an estimated $628K.
  • Axsome Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #1574 holding.
  • Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and has held it in 30 quarters since.
  • Simplex Trading's Axsome Therapeutics position peaked at $4.81M in Q2 2026.
  • 235 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.